BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34937173)

  • 1. Recombinant Fasciola hepatica Fatty Acid Binding Protein as a Novel Anti-Inflammatory Biotherapeutic Drug in an Acute Gram-Negative Nonhuman Primate Sepsis Model.
    Rosado-Franco JJ; Armina-Rodriguez A; Marzan-Rivera N; Burgos AG; Spiliopoulos N; Dorta-Estremera SM; Mendez LB; Espino AM
    Microbiol Spectr; 2021 Dec; 9(3):e0191021. PubMed ID: 34937173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fh15 Blocks the Lipopolysaccharide-Induced Cytokine Storm While Modulating Peritoneal Macrophage Migration and CD38 Expression within Spleen Macrophages in a Mouse Model of Septic Shock.
    Ramos-Benitez MJ; Ruiz-Jimenez C; Rosado-Franco JJ; Ramos-Pérez WD; Mendez LB; Osuna A; Espino AM
    mSphere; 2018 Dec; 3(6):. PubMed ID: 30567900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands.
    Ramos-Benítez MJ; Ruiz-Jiménez C; Aguayo V; Espino AM
    Sci Rep; 2017 Jul; 7(1):5455. PubMed ID: 28710478
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Valdes-Fernandez BN; Ruiz-Jimenez C; Armina-Rodriguez A; Mendez LB; Espino AM
    bioRxiv; 2023 Aug; ():. PubMed ID: 37609327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo.
    Martin I; Cabán-Hernández K; Figueroa-Santiago O; Espino AM
    J Immunol; 2015 Apr; 194(8):3924-36. PubMed ID: 25780044
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Valdes-Fernandez BN; Ruiz-Jimenez C; Armina-Rodriguez A; Mendez LB; Espino AM
    Microbiol Spectr; 2024 Jan; 12(1):e0347523. PubMed ID: 38018982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
    Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
    Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides.
    Robinson MW; Donnelly S; Hutchinson AT; To J; Taylor NL; Norton RS; Perugini MA; Dalton JP
    PLoS Pathog; 2011 May; 7(5):e1002042. PubMed ID: 21589904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasciola hepatica GST downregulates NF-κB pathway effectors and inflammatory cytokines while promoting survival in a mouse septic shock model.
    Aguayo V; Valdés Fernandez BN; Rodríguez-Valentín M; Ruiz-Jiménez C; Ramos-Benítez MJ; Méndez LB; Espino AM
    Sci Rep; 2019 Feb; 9(1):2275. PubMed ID: 30783117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasciola hepatica: molecular cloning, nucleotide sequence, and expression of a gene encoding a polypeptide homologous to a Schistosoma mansoni fatty acid-binding protein.
    Rodríguez-Pérez J; Rodríguez-Medina JR; García-Blanco MA; Hillyer GV
    Exp Parasitol; 1992 Jun; 74(4):400-7. PubMed ID: 1592092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasciola hepatica fatty acid binding protein (Fh12) induces apoptosis and tolerogenic properties in murine bone marrow derived dendritic cells.
    Ruiz-Jiménez C; Celias D; Valdés B; Ramos-Pérez WD; Cervi L; Espino AM
    Exp Parasitol; 2021 Dec; 231():108174. PubMed ID: 34752732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprophylaxis against Fasciola hepatica in rabbits using a recombinant Fh15 fatty acid-binding protein.
    Casanueva R; Hillyer GV; Ramajo V; Oleaga A; Espinoza EY; Muro A
    J Parasitol; 2001 Jun; 87(3):697-700. PubMed ID: 11426738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of Fasciola hepatica excretory and secretory products (FhESPs) involved in interacting with host PBMCs and cytokines by shotgun LC-MS/MS.
    Liu Q; Huang SY; Yue DM; Wang JL; Wang Y; Li X; Zhu XQ
    Parasitol Res; 2017 Feb; 116(2):627-635. PubMed ID: 27866265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD.
    López-Abán J; Casanueva P; Nogal J; Arias M; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Muro A
    Vet Parasitol; 2007 Apr; 145(3-4):287-96. PubMed ID: 17275191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outlining key inflammation-associated parameters during early phase of an experimental gram-negative sepsis model in rhesus macaques (
    Rosado-Franco JJ; Ramos-Benitez MJ; Parodi LM; Rosario D; Compo N; Giavedoni LD; Espino AM
    Animal Model Exp Med; 2019 Dec; 2(4):326-333. PubMed ID: 31942564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune modulatory peptide FhHDM-1 secreted by the helminth Fasciola hepatica prevents NLRP3 inflammasome activation by inhibiting endolysosomal acidification in macrophages.
    Alvarado R; To J; Lund ME; Pinar A; Mansell A; Robinson MW; O'Brien BA; Dalton JP; Donnelly S
    FASEB J; 2017 Jan; 31(1):85-95. PubMed ID: 27682204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased TLR4 Expression Aggravates Sepsis by Promoting IFN-
    Li Q; Wu C; Liu Z; Zhang H; Du Y; Liu Y; Song K; Shi Q; Li R
    J Immunol Res; 2019; 2019():3737890. PubMed ID: 30915370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of mice against schistosoma bovis with a recombinant fatty acid binding protein from Fasciola hepatica.
    Abáné JL; Oleaga A; Ramajo V; Casanueva P; Arellano JL; Hillyer GV; Muro A
    Vet Parasitol; 2000 Jul; 91(1-2):33-42. PubMed ID: 10889358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human resistin protects against endotoxic shock by blocking LPS-TLR4 interaction.
    Jang JC; Li J; Gambini L; Batugedara HM; Sati S; Lazar MA; Fan L; Pellecchia M; Nair MG
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10399-E10408. PubMed ID: 29133417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis.
    Jessen KM; Lindboe SB; Petersen AL; Eugen-Olsen J; Benfield T
    BMC Infect Dis; 2007 Sep; 7():108. PubMed ID: 17877801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.